“Clinical Trial Management: Monitoring Progress, Sites and Safety; New Paradigms for Efficiency”, in 5th Annual Clinical Research Management Workshop at the Yale Center for Clinical Investigation, New Haven, CT, 2012.
, “Design and Methodological Considerations of an Effectiveness Trial of a Computer-Assisted Intervention: An Example from the NIDA Clinical Trials Network”, Contemp Clin Trials, vol. 33, pp. 386-395, 2012.
, “Estimating Death Rates In Substance Use Disorder”, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
, “Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World”, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.
, “How Electronic Health Records (EHRs) Can Support Comparative Effectiveness Research (CER)”, in Annual Comparative Effectiveness Research Key Function Committee Meeting, Rockville, MD, 2012.
, “Implementation of a Drug Management Utility in a Multi-Site, Randomized, Double-Blinded Study”, in Society for Clinical Trials Annual Meeting, Miami, FL, 2012.
, “Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)”, in College on Problems of Drug Dependence Meeting, San Diego, CA, 2013.
, “Induction onto Extended-release Naltrexone in 302 Cocaine-dependent Opioid Users”, in College on Problems of Drug Dependence Meeting, San Diego CA, 2013.
, “Investigator Attestation Poster”, in Society of Clinical Research Associates - SoCRA, 22nd Annual Conference, 2013.
, “The National Drug Abuse Treatment Clinical Trials Network Data Share Project: Website Design, Usage, Challenges, and Future Directions”, Clin Trials, vol. 10, pp. 977-986, 2013.
, “SCORE Study Report 12: Development of Venous Collaterals in the SCORE Study”, Retina, vol. 33, pp. 287-295, 2013.
, “Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network”, Contemp Clin Trials, vol. 39, pp. 211-223, 2014.
, “Implications of Modifying Study Eligibility Criteria Post-Initiation of Recruitment”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial”, Am J Psychiatry, vol. 171, pp. 683-690, 2014.
, “Non Clinical Parameters Affecting Primary Cesarean Rates in the United States”, Am J Perinatol, vol. 31, pp. 213-222, 2014.
, “Patient Registries for Substance Use Disorders”, Subst Abuse Rehabil, vol. 5, pp. 81-86, 2014.
, “Tracking and Monitoring Trial Progress in NIDA CTN Studies”, in NIH Workshop on Enrollment and Retention of Participants in NIH-funded Clinical Trials, Bethesda, MD, 2014.
,